Sources + Company Details.
-----
As mentioned above, BCAN has several potential breakout catalysts that you need to familiarize yourself with quickly. Check these out:
No. 1 BCAN Potential Catalyst - Could A Float This Small Lead To Explosive Volatility? (Under 1Mn Shares)
According to the Yahoo Finance website, BCAN has an exceptionally tiny float.
In fact, the website reports this profile to have approximately 464.22k shares in its float.
Why is that important? It's important on one crucial level. Volatility potential.
Could more positive company news in beginning of 2025 provide a near term spark?
-----
No. 2 BCAN Potential Catalyst - CES Las Vegas Could Be A Major Jumping Off Point For Company's Flagship Product.
AI Innovative Award of the 2025 CES Competition to Include Femto Flagship Product
Femto Technologies Inc., formerly known as BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) ("Femto" or the "Company"), a leading innovator in the FemTech industry, has submitted its flagship feminine wellness product to the CES Innovation Awards competition, scheduled to be announced in January 2025. ...
CES is the most powerful tech event in the world, the proving ground for breakthrough technologies and global innovators. The CES Innovation Awards annual competition celebrates outstanding design and engineering in consumer technology products. The program recognizes honorees in various categories, distinguishing the highest-rated products as Best of Innovation. Femto will be competing in the Embedded Technologies and AI categories.
...
"We are thrilled to be evaluated by a panel of industry experts based on criteria, such as innovation, engineering, functionality, and aesthetics, all of which are key components in our product," explained Yftah Ben Yaackov, CEO of Femto. "We value the opp. to shine a light on the importance of women's health, pleasure, and overall wellbeing and our commitment to improving technology-driven personalization for women."
Read the full article here.
-----
No. 3 BCAN Potential Catalyst - Important Milestone Reached As Femto Partners With Key FDA-Registered Manufacturer.
Femto Partners With FDA-Registered Manufacturer to Launch Flagship AI-Driven FemTech Product's Pods
VANCOUVER, British Columbia and LOS ANGELES, CA - (NewMediaWire) - September 04, 2024 - Femto Technologies Inc., ..., acts to summarize commercial conditions with an FDA-registered facility to produce 510(k) lubricants, integral to Femto's flagship product, soon to be launched in the US.
This collaboration is part of the company's agenda to upgrade its flagship product to a medical device 510(k) FDA approved.
The 510(k) Premarket Notification, as mandated by the Food, Drug, and Cosmetic Act, requires manufacturers to notify the FDA of their intent to market a medical device at least 90 days in advance. This process allows the FDA to determine whether the device is equivalent to an existing device in one of the three classification categories. Manufacturers must submit a premarket notification if they intend to introduce a device into commercial distribution for the first time or significantly modify an existing device in a way that could affect its safety or effectiveness.
...
"We have identified an outstanding professional FDA-approved partner that aligns with Femto's innovative DNA and vision to enhance women's wellness globally," explained Yftah Ben Yaackov, CEO of Femto. "All of Femto's lubricants will meet the 510(k) requirements. Meeting these high standards is the first milestone in regulating our flagship product as a medical device, this partnership ensures that our products meet the highest standards of safety and efficacy, allowing us to deliver unparalleled value to our customers."
The chosen facility also holds certifications from the International Compliance Association (ICA), California Department of Public Health, Women Business Enterprise (WBENC), and CCOF (Organic), among others.
...
Read the full article here.
-----
No. 4 BCAN Potential Catalyst - A Revenue Growth Pop Could Signal Big Things Ahead for Femto.
Femto Technologies Reports Increase in Revenue and Transition to Net Pro-fit for the Second Quarter of 2024
VANCOUVER, BC - (NewMediaWire) - August 14, 2024 - Femto Technologies Inc. (Nasdaq: BCAN) ("Femto" or the "Company"), an integrated software company specializing in female technology, has released its fin.an.cial results for six-month ended June 30, 2024. Full versions of Femto's unaudited consolidated interim fin.an.cial statements and management discussion and analysis for the period, can be found on www.sedarplus.ca.
Q2 2024 Financial Highlights:
- Revenue increased 62% to $405+k for the three-month period ended June 30, 2024, from $251+k for the same period in 2023.
- Revenue increased 6% to $714+k for the six-month period ended June 30, 2024, from $671+k for the same period in 2023.
- Gross Pro-fit increased to 27% for the three-month period ended June 30, 2024, from 26% for the same period in 2023.
...
Read the full article here.
-----
(Nasdaq: BCAN) Recap - The Top 4 Potential Breakout Catalysts On My Radar
No. 1 - Could A Float This Small Lead To Explosive Volatility? (Under 1Mn Shares)
No. 2 - CES Las Vegas Could Be A Major Jumping Off Point For Company's Flagship Product.
No. 3 - Important Milestone Reached As Femto Partners With Key FDA-Registered Manufacturer.
No. 4 - A Revenue Growth Pop Could Signal Big Things Ahead for Femto.
-----
Coverage is officially initiated on (Nasdaq: BCAN). I'll be in touch with updates when necessary.
Sincerely,
Kai Parker
StockWireNews
(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)
